Sagimet Biosciences SGMT
NASDAQ SGMT
$10.85 -0.04 (-0.37%)
As of: Nov 11, 2026 · 9:30 AM EST

Sagimet Biosciences (SGMT) Net Equity Issued and Repurchased (2023 - 2025)

Updated

Sagimet Biosciences' Net Equity Issued and Repurchased was -$25,000 in Q4 2025.

Analysis

Sagimet Biosciences (SGMT) Net Equity Issued and Repurchased (2023 - 2025) Analysis & Trends

For FY2025, Net Equity Issued and Repurchased at Sagimet Biosciences came in at $275,000, down 99.7% from FY2024.

  • Net Equity Issued and Repurchased shows a three-year compound annual growth rate of 184.0% (FY2022 to FY2025).
  • In earlier years, Net Equity Issued and Repurchased was $105.75 million in FY2024 (+17.9%), $89.68 million in FY2023 and $12,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Sagimet Biosciences 578.42 Mn 3.93 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -25,000.00
Sep 30, 2025 299,000.00
Mar 31, 2024 105.86 Mn
Dec 31, 2023 3.52 Mn
Sep 30, 2023 86.17 Mn
API Access

Sagimet Biosciences Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=SGMT&period=max&api_key=YOUR_API_KEY